Ads
related to: boston scientific stock price targetwallstreetwatchdogs.com has been visited by 10K+ users in the past month
signup.chaikinanalytics.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Price Action: BSX stock is down 1.66% at $83.16 at last check Wednesday. Read Next: CDW Shares Dip As Q3 Sales Miss Amid Weak Hardware Demand And Customer Delays
Boston Scientific acquired Target Therapeutics in a tax-free stock swap for about $1.1 billion, more than 10 times Target's total sales, in contrast to the usual multiple of 10 times earnings. [ 14 ] The Taxus Stent was approved in 2003 in Europe and other countries and, in the United States, by the FDA in March 2004.
** The median price target for Boston Scientific is $61, a 19.7% upside to its last closing price on Tuesday. (Reporting by Khushi Mandowara and Mariam Sunny in Bengaluru; Editing by Sriraj Kalluvila)
Boston Scientific forecast a full-year profit on Wednesday that was largely ahead of analysts' estimates and said the U.S. health regulator has approved its heart device, sending the company's ...
Favorable COVID-19 vaccine developments have revived the hopes of several companies that have seen demand for their products crushed by the unprecedented pandemic. That said, the recent spike in ...
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States.The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products.